GILD
GILD
US3755581036
Gilead Sciences, Inc.
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 55/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
6/7 High
6 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.3x).

Beta (Market Relation)
0.33x
Defensive
Volatility (5Y p.a.)
24.8% p.a.
5-Year Horizon
Max Drawdown (5Y)
-29.4%
5-Year Horizon
Sharpe Ratio
0.57
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +24.4%
3 Years 26.2% -27.6% 0.86 +25.1%
5 Years 24.8% -29.4% 0.57 +16.7%
10 Years 25.6% -36.2% 0.17 +6.9%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 223%.
ende